NEW DELHI: Primary Vaccine Serum institute India on Sunday rejected allegations that a Covid-19 candidate vaccine has serious side effects and threatened to seek large compensation for “malicious” allegations. A 40-year-old man who took part in the ‘Covidshield’ vaccine trial in Chennai has alleged serious side effects, including virtual neurological …
Read More »
By: PTI | Chennai | Updated: November 29, 2020 5:43:01 pm The man, he alleged, suffered from acute encephalopathy, damage or disease that affects the brain, after vaccination and all tests confirmed that the setback in his health was due to the test vaccine. A 40-year-old man who took part …
Read More »
Adar Poonawalla said that he discussed the implementation plan with PM Modi. The Serum Institute will request in two weeks the emergency use of the coronavirus vaccine being developed by the University of Oxford and the pharmaceutical giant AstraZeneca, the head of the vaccine manufacturer, Adar Poonawalla, said on Saturday …
Read More »
“The scientists expressed their joy that the prime minister was meeting with them face to face in order to boost their morale and help accelerate their efforts at this critical juncture in the vaccine development journey – such a rapid pace thus far. He spoke about how India is following …
Read More »
IBS is conducting clinical trials of AstraZeneca-Oxford’s COVID-19 vaccine in India. (Representative) New Delhi: The leading Serum Institute of India for vaccines said Thursday that the COVID-19 vaccine developed by AstraZeneca and the University of Oxford is safe and effective, and that Indian trials are progressing smoothly with strict adherence …
Read More »
Even if a vaccine against coronavirus is available early next year, healthy adults, without any underlying disease, are unlikely to receive it before 2022, according to a new book ‘Till We Win: India’s Fight Against The COVID-19 Pandemic’. The book is co-authored by AIIMS Director Randeep Guleria, Public Policy and …
Read More »
New Delhi: Serum Institute can sell Covishield covid-19 vaccine in approximately ₹500- ₹600 per dose in the private market, about double the $ 3 per injection it will cost the Indian government, as well as the COVAX facility, CEO Adar Poonawalla said at the Hindustan Times Leadership Summit on Thursday. …
Read More »
NEW DELHI: As the national expert group on the Covid-19 vaccine strengthens plans for the procurement and distribution of injections, the Center is betting on the five candidate vaccines currently in clinical trials in India. Candidates include three that are in advanced stages of trials in India: the Oxford-AstraZeneca candidate …
Read More »
NEW DELHI: India is in dialogue with US biotech giant Moderna about progress in clinical trials of its coronavirus vaccine candidate, which the firm says has shown 94.5 percent efficacy, official sources said Monday. Moderna said Monday that the Data Safety Monitoring Board (DSMB) appointed by the independent National Institutes …
Read More »
The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 injection, aiming to have 100 million doses ready by December for an inoculation campaign that could begin across India later that month. If the data from the end-stage trial shows that AstraZeneca’s candidate provides effective protection against …
Read More »